This report is an adjunct to the American Gastroenterological Association Institute's medical
position statement and technical review on the management of Barrett's esophagus, which …

Background and Aims A small but significant proportion of patients with Barrett's esophagus
(BE) have persistent dysplasia or intestinal metaplasia (IM) after treatment with …

BACKGROUND: Endoscopic ablation to treat Barrett's esophagus (BE) with high-grade
dysplasia (HGD) is associated with a decreased incidence of esophageal adenocarcinoma …

Background Radiofrequency ablation (RFA) is an effective treatment for Barrett's esophagus
(BE) dysplasia. For patients with dysplasia refractory to RFA, data are limited regarding …

Background and study aims: Endoscopic cryotherapy has been used successfully for the
ablation of Barrett's esophagus but outcome data are limited. The aim of this study was to …

Current Opinion in Gastroenterology Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …

This chapter describes the pathways to convert emitted (or otherwise wasted) CO2 into more
valuable products or chemical feedstock (CU) as means for adding value or creating …

Background: Cryotherapy is a relatively novel ablation modality for the endoscopic ablation
of Barrett's esophagus (BE). Data on the use of pressurized carbon dioxide (CO 2) gas for …

Approximately 16,500 Americans are diagnosed with esophageal cancer and 14,500 die of
this malignancy each year. 1 The incidence of esophageal adenocarcinoma has continued …

Barrett's esophagus (BE) is the only established precursor lesion in the development of
esophageal adenocarcinoma (EAC) and it increases the risk of cancer by 11-fold. It is …